GW Pharmaceuticals Plc

(GWPRF)

By |

Profile

GW Pharmaceuticals PLC is a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform in a broad range of disease areas. Its business activities are functioned through three reportable segments which are Commercial, Sativex Research and Development and Pipeline Research and Development. The company's lead product candidate is Epidiolex, which is a liquid formulation of pure plant-derived cannabidiol used for the treatment of a number of rare childhood-onset epilepsy disorders. The company also develops and markets Sativex, an oromucosal spray for the treatment of spasticity due to multiple sclerosis. Geographically its presence can be seen across the region of UK, Europe, US, Canada, and others.

Contact Information

Website: www.gwpharm.com
Email: publicrelations@gwpharm.com
Main Phone: +44 1223266800
Address: Sovereign House, Chivers Way
Address 2: Vision Park, Histon
City / Town: Cambridge
Country: GBR
Postal Code: CB24 9BZ

Issuer Information

Exchange: OTO
CEO: Justin David Gover
Employees: 769


Gathering Data... Please wait

Profile

GW Pharmaceuticals PLC is a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform in a broad range of disease areas. Its business activities are functioned through three reportable segments which are Commercial, Sativex Research and Development and Pipeline Research and Development. The company's lead product candidate is Epidiolex, which is a liquid formulation of pure plant-derived cannabidiol used for the treatment of a number of rare childhood-onset epilepsy disorders. The company also develops and markets Sativex, an oromucosal spray for the treatment of spasticity due to multiple sclerosis. Geographically its presence can be seen across the region of UK, Europe, US, Canada, and others.

Contact Information

Website: www.gwpharm.com
Email: publicrelations@gwpharm.com
Main Phone: +44 1223266800
Address: Sovereign House, Chivers Way
Address 2: Vision Park, Histon
City / Town: Cambridge
Country: GBR
Postal Code: CB24 9BZ

Issuer Information

Exchange: OTO
CEO: Justin David Gover
Employees: 769
$ 11.31 $ 0.14 (1.22%)
Last Price 11.31 Change $ 0.14 Change % 1.22 Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open 11.45 High 11.90 Low 11.10 Prev Close 11.17
Last Trade Volume 10,310 52 Wk Hi 15.00 52 Wk Low 7.07
Market Cap 4.1 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 366,515,500.00 EPS (TTM) -0.90 PE Ratio N/A Exchange OTCPK